Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Sponsor: Pfizer
Summary
The purpose of this study is to evaluate: * What is the real-world effectiveness of elranatamab in patients with relapsed and/or refractory multiple myeloma (RRMM) in Taiwan? * What are the baseline and clinical characteristics of RRMM patients who have received eltanatamab in Taiwan? * What are the treatment patterns of RRMM patients receiving elranatamab in the real-world setting in Taiwan?
Official title: A Multi-center Observational Study of the Effectiveness of Elranatamab in Patients With Relapsed and/or Refractory Multiple Myeloma in Taiwan
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-03-31
Completion Date
2028-01-31
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Interventions
Non intervention
Non intervention
Locations (1)
Taichung Veterans General Hospital
Taichung, Taiwan